Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doreen Campbell

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Vaccine|September 16, 2022
Safety and immunogenicity of the Na-APR-1 hookworm vaccine in infection-naïve adultsDavid J Diemert, Maria Zumer, Doreen Campbell, et al.
Plos Neglected Tropical Diseases|January 8, 2025
Randomized, observer-blind, controlled Phase 1 study of the safety and immunogenicity of the Na-GST-1/Alhydrogel hookworm vaccine with or without a CpG ODN adjuvant in hookworm-naïve adultsDavid J Diemert, Maria Zumer, Mark Bova, et al.
Open Forum Infectious Diseases|May 22, 2018
Controlled Human Hookworm Infection: Accelerating Human Hookworm Vaccine DevelopmentDavid Diemert, Doreen Campbell, Jill Brelsford, et al.
Plos Neglected Tropical Diseases|February 14, 2017
Advances in neglected tropical disease vaccines: Developing relative potency and functional assays for the Na-GST-1/Alhydrogel hookworm vaccineJill B Brelsford, Jordan L Plieskatt, Anna Yakovleva, et al.
Plos Neglected Tropical Diseases|August 18, 2020
Correction: Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adultsDavid J Diemert, Janaína Freire, Vanderson Valente, et al.
Plos Neglected Tropical Diseases|May 3, 2017
Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adultsDavid J Diemert, Janaína Freire, Vanderson Valente, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Vaccine|September 16, 2022
Safety and immunogenicity of the Na-APR-1 hookworm vaccine in infection-naïve adultsDavid J Diemert, Maria Zumer, Doreen Campbell, et al.
Plos Neglected Tropical Diseases|January 8, 2025
Randomized, observer-blind, controlled Phase 1 study of the safety and immunogenicity of the Na-GST-1/Alhydrogel hookworm vaccine with or without a CpG ODN adjuvant in hookworm-naïve adultsDavid J Diemert, Maria Zumer, Mark Bova, et al.
Open Forum Infectious Diseases|May 22, 2018
Controlled Human Hookworm Infection: Accelerating Human Hookworm Vaccine DevelopmentDavid Diemert, Doreen Campbell, Jill Brelsford, et al.
Plos Neglected Tropical Diseases|February 14, 2017
Advances in neglected tropical disease vaccines: Developing relative potency and functional assays for the Na-GST-1/Alhydrogel hookworm vaccineJill B Brelsford, Jordan L Plieskatt, Anna Yakovleva, et al.
Plos Neglected Tropical Diseases|August 18, 2020
Correction: Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adultsDavid J Diemert, Janaína Freire, Vanderson Valente, et al.
Plos Neglected Tropical Diseases|May 3, 2017
Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adultsDavid J Diemert, Janaína Freire, Vanderson Valente, et al.
Pageof 1